Contribute Try STAT+ Today

Two dozen U.K. lawmakers called on the government to publish all communications with drug makers in order to assess whether industry lobbying influenced opposition to a proposal before the World Trade Organization designed to widen access to Covid-19 vaccines in low and middle-income countries.

Their move comes amid controversy over the proposal, which was introduced last fall and would temporarily waive trade agreement provisions governing patents, industrial designs, copyrights, and protection of undisclosed information, a reference to trade secrets. So far, the effort has support from 100 WTO members.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.